A pair of former venture partners at Japanese conglomerate Mitsui & Co are eyeing up to $150m for a new fund dedicated to biopharmaceutical deals.
Remiges Biopharma will be led by Taro Inaba, Mitsui’s former general manager for healthcare and cleantech investment, and ex-Mitsui Venture Partners executive Walter Olesiak.
Olesiak is currently a managing director at Connectis Ventures according to his LinkedIn profile.
Remiges is yet to pick up any commitments according to a regulatory filing.
Mitsui is a major venture capital investor in Japan and the wider Asia region, and currently does deals through its Mitsui Global Investment arm.
Copyright © 2014 AltAssets